Showing results (2631-2640 of 5,590) with videos related to

Sort By:
Pageof 559
Theranostics|April 11, 2025
Acetylation-regulated DUSP1 deficiency contributes to renal fibrosis progressionShaobo Wang, Bo Zhang, Yaqin Wang, et al.
Theranostics|April 11, 2025
Transcranial ultrasound localization microscopy in moyamoya patients using a clinical ultrasound systemLouise Denis, Elena Meseguer, Augustin Gaudemer, et al.
Theranostics|April 11, 2025
Dual targeting PET tracer [68Ga]Ga-PSFA-01 in patients with prostate cancers: A pilot exploratory studyYue Li, Lili Guan, Xiaoyang Zhang, et al.
Theranostics|June 7, 2023
The STAT1/HMGB1/NF-κB pathway in chronic inflammation and kidney injury after cisplatin exposureYing Fu, Yu Xiang, Ying Wang, et al.
Theranostics|June 7, 2023
Current advances in temozolomide encapsulation for the enhancement of glioblastoma treatmentNerea Iturrioz-Rodríguez, Nicolas Sampron, Ander Matheu
Theranostics|June 7, 2023
NOX4 is a potential therapeutic target in septic acute kidney injury by inhibiting mitochondrial dysfunction and inflammationJiameng Li, Liya Wang, Bo Wang, et al.
Theranostics|June 7, 2023
Mechanical force drives the initial mesenchymal-epithelial interaction during skin organoid developmentMengyue Wang, Xun Zhou, Siyi Zhou, et al.
Theranostics|March 9, 2026
In vivo Expansion of Regulatory T cells via an Engineered IL-2 Mutein to Suppress Autoimmune GlomerulonephritisHuang Kuang, Cai-Xia Lin, Jing Huang, et al.
Theranostics|March 9, 2026
Specific in vivo detection of V2R-positive metastatic ccRCC using a toxin-based PET radioligandGoran Stanajic Petrovic, Khawla Chmeis, Alix Gonand, et al.
Theranostics|March 9, 2026
Globo H ceramide confers chemoresistance and poor prognosis to advanced gallbladder cancer via A2AR/cAMP/PKA pathwayTsai-Hsien Hung, Jung-Tung Hung, Wen-Kuan Huang, et al.
Pageof 559